Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metovav 23.75mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Inavars Biologicals Inc

Salt Composition

Metoprolol Succinate (23.75mg)

Overview Metovav 23.75mg Tablet ER

CardioBeta 23.75mg Extended-Release tablets are classified as beta-adrenergic blockers. This medication treats hypertension (high blood pressure), angina pectoris (chest pain due to heart issues), and cardiac arrhythmias (irregular heartbeats). It's also used to prevent migraine headaches, future myocardial infarctions (heart attacks), and cerebrovascular accidents (strokes). CardioBeta 23.75mg ER may be administered independently or in conjunction with other therapies. Dosage and frequency are determined by the treated condition and its severity. It can be taken with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic benefits may take weeks to manifest, and continuous use might be necessary. Discontinuing treatment, even with symptom improvement, can exacerbate the underlying condition. Common side effects, often mild and transient, include fatigue, cephalalgia (headache), depressive symptoms, diarrhea, skin rash, bradycardia (slow heart rate), dizziness, and nausea. Less frequent side effects include dyspnea (shortness of breath) and hypotension (low blood pressure). Gradual dose escalation minimizes adverse reactions. Report persistent or troublesome side effects to your physician. Prior to commencing treatment, inform your doctor of any hepatic (liver) impairment. This medication may be unsuitable for individuals with bradycardia, significant circulatory disorders, severe congestive heart failure, or hypotension. Pregnant or lactating women should seek medical advice. Always consult your doctor to assess suitability. Regular blood pressure monitoring ensures therapeutic effectiveness. Alcohol consumption should be limited due to potential exacerbation of side effects.

Uses of Metovav 23.75mg Tablet ER

Managing angina pectoris (chest pain due to heart issues) | Correcting cardiac arrhythmias | Reducing the risk of myocardial infarction | Controlling hypertension (high blood pressure) | Preventing migraine episodes

Major Benefits of Metovav 23.75mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Metovav 23.75mg Extended-Release Tablets. Swallow the tablet whole; do not chew, crush, or divide it. These tablets can be taken with or without food, but consistency in timing is recommended. Minimize consumption of high-fat foods like olive oil, nuts (including Brazil nuts), dark chocolate, butter, and fatty meats while taking Metovav 23.75mg ER Tablets.

Common Side effects of Metovav 23.75mg Tablet ER:

  • Tiredness
  • Dizziness
  • Depression
  • Breathlessness
  • Headache
  • Slow heart rate
  • Nausea
  • Rash
  • Diarrhea
  • Hypotension (low blood pressure)

How to use Metovav 23.75mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Metovav 23.75mg Extended-Release Tablets. Swallow the tablet whole; do not chew, crush, or break it. These tablets can be taken with or without food, but consistent timing is recommended. Minimize consumption of high-fat foods, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and fatty meats, while taking Metovav 23.75mg ER tablets.

How Metovav 23.75mg Tablet ER works:

Extended-release Metovav 23.75mg tablets are a cardioselective beta-blocker designed to prolong the duration of therapeutic effects. The medication reduces heart rate and improves the heart's pumping efficiency, thereby enhancing circulatory function.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Metovav 23.75mg Extended-Release Tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Metovav 23.75mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Metovav 23.75mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Extended-release Metovav 23.75mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Metovav 23.75 mg tablets are considered safe for individuals with impaired kidney function. No alteration of the Metovav 23.75 mg extended-release tablet dosage is necessary.

LiverLiverCAUTION

Extended-release Metovav 23.75mg tablets require careful administration for individuals with hepatic impairment. Dosage modification of Metovav 23.75mg extended-release tablets may be necessary. Physician consultation is advised.

What if you forget to take Metovav 23.75mg Tablet ER :

Should you forget a Metovav 23.75mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metovav 23.75mg Tablet ER

LabelValue
Chemical Category Alcohols and Phenols
Developing Habits No.
Type of Therapy HEART

FAQs on Metovav 23.75mg Tablet ER

Metovav 23.75mg Tablet ER's onset varies individually; effects typically begin within 15 minutes, but may take up to 2 hours. Full effectiveness usually develops over a week. Don't be alarmed if you don't notice immediate changes; this medication's benefits become apparent with continued use.
Metovav 23.75mg Extended-Release tablets are generally safe when used as directed by your doctor. However, abruptly discontinuing this medication can be hazardous, potentially causing a rapid increase in heart rate and disrupting heart function. This risk is particularly significant for patients with heart failure and may even lead to a heart attack. Therefore, never stop taking Metovav suddenly; continue as prescribed.
Metovav 23.75mg Extended-Release tablets are beta-blockers. While individual responses vary, they may disrupt sleep in some, but can improve sleep in others by reducing anxiety and heart rate. Consult your doctor about any sleep problems.
Avoid alcohol while taking Metovav 23.75mg Extended-Release tablets. Alcohol can intensify the medication's blood pressure-lowering effect, potentially causing dangerously low blood pressure.
Metovav 23.75mg Tablet ER
38
MRP 44
14% off